CHADS(2) and CHA(2)DS(2)-VASc Scores Can Guide the Evaluation of Cryptogenic Ischemic Stroke

EKİZOĞLU TURGUT, ESME; Atmaca, Murat; Cinar-Balcioglu, Çağla; YEŞİLOT, NİLÜFER; ÇOBAN, Oğuzhan

doi:10.4103/0028-3886.333477

CHADS(2) and CHA(2)DS(2)-VASc Scores Can Guide the Evaluation of Cryptogenic Ischemic Stroke

EKİZOĞLU TURGUT E., Atmaca M. M., Cinar-Balcioglu C., YEŞİLOT N., ÇOBAN O.

NEUROLOGY INDIA, cilt.69, sa.6, ss.1716-1721, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 69 Sayı: 6
Basım Tarihi: 2021
Doi Numarası: 10.4103/0028-3886.333477
Dergi Adı: NEUROLOGY INDIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.1716-1721
Anahtar Kelimeler: CHADS(2), CHA(2)DS(2)-VASc, cryptogenic stroke, INCIDENT ATRIAL-FIBRILLATION, UNDETERMINED SOURCE, EMBOLIC STROKE, RISK STRATIFICATION, PREVENTION, MANAGEMENT, PREDICT
İstanbul Üniversitesi Adresli: Evet

Özet

Background and Aims: Cryptogenic ischemic strokes (CIS) are treated with antiplatelets for stroke prevention in routine clinical practice. The objective of this study was to investigate whether the CHADS(2) and CHA(2)DS(2)-VASc scores may be used to identify the patients with CIS at higher risk of ischemic stroke despite antiplatelet therapy.